Pertuzumab Update: The New Kid on “HER” Block

  Although trastuzumab has led to significant improvements in treating HER2-positive breast cancers, many patients relapse and develop resistance to trastuzumab. The HER family of growth factor receptors consists of four closely related… [Learn More…]